Real-life study of dual therapy based on dolutegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients.

Elżbieta JabłonowskaEwa SiwakMonika Bociąga-JasikJacek GąsiorowskiAnna KalinowskaEwa Firląg BurkackaKamila Wójcik-CichyAnna PiątekIwona CielniakAndrzej Horban

Published in: PloS one (2019)

The investigated dual therapy was effective and safe. The observed increase in lipid parameters only concerned the patients who had used a TDF-based regimen prior to analysed dual treatment.

Keyphrases

hiv infected
antiretroviral therapy
newly diagnosed
hiv infected patients
stem cells
combination therapy
replacement therapy
hepatitis c virus
high resolution